Paninsuro, Elma C.

HRN: 28-90-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2026
CEFTRIAXONE 1G (VIAL)
04/25/2026
05/01/2026
IV
2g
OD
Complicated UTI Prob. Sec To Obstructig Nephrolithiasis, L
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: